Echelon Resources (ASX: ECH) announces non-binding terms with NT’s Power and Water Corporation for gas supply from Mereenie & Palm Valley JVs through 2034. ASX announcement: https://t.co/EVycjr4bOs

_ @4DMedicalXV (ASX: 4DX) secures Canadian regulatory approval for CT:VQ™, the world’s first non-contrast CT-based ventilation-perfusion imaging solution. Strengthens Philips partnership & enables immediate rollout across North America. ASX announcement: https://t.co/QFZ5mGvt3e

A year in review for @KincoraCopper & what’s ahead in 2026. CEO @Sam_J_Spring joins Kerry Stevenson on @GoldEventsAU to discuss exploration progress, how the prospect-generator model cuts dilution & attracts partners like AngloGold Ashanti https://t.co/JQa17w6x2t

Nickel Industries (ASX:NIC) Hengjaya Mine has received approval to extend its 2025 nickel ore sales quota from 9 million wmt to 10.5 million wmt for the remainder of 2025, enabling immediate recommencement of ore sales into the IMIP via both haul road and barging.

_ @EBRSystemsInc (ASX:EBR) has announced the grant of four new patents, reinforcing the protection of its world-first WiSE® wireless cardiac pacing technology. ASX announcement: https://t.co/Zskt4gJ4te

_ @KincoraCopper (ASX/TSXV: KCC) updates on drilling across 7 licences (results pending). JV with AngloGold Ashanti reviews promising Nevertire Magmatic Complex results. Strong momentum continues into next year.

_ @OncoSil_Medical (ASX: OSL) is proud to announce the first commercial use of the OncoSil™ device in the UK. The treatment was performed on 9 December 2025 at Southampton General Hospital, a recognised centre of excellence in oncology. Read more: https://t.co/CudmvJtH4u

4DMedical has announced that the University of Miami (UMiami) has entered into a commercial arrangement for the clinical use of CT:VQ™, while Lahey Hospital & Medical Center has signed a two-year agreement for IQ-UIP™ | ASX announcement: https://t.co/r4dnF0Cqxc @4DMedicalXV

Race Oncology (ASX:RAC) has secured A$3.22 million through a private placement to fully fund and commence its HARNESS-1 Phase 1a/b trial in non-small cell lung cancer, with first patient enrolment expected in early Q1 2026 | https://t.co/z3tKlUpcX1 @RaceOncology $RAC

Great to showcase @KincoraCopper's exploration & funding strategy at IMARC 2025. Our panel, “Elephant Hunting in the Macquarie Arc,” highlighted major discovery potential across the Arc, including Kincora’s work with AngloGold Ashanti. Watch here: https://t.co/y8PrGYCLA1

_ @Optiscan_ held an investor webinar today at 11am AEDT, where CEO Dr Camile Farah outlined the Company’s growth strategy following its recent $17.75m equity raise, and progress across its digital endomicroscopy portfolio InVue®, InForm™ & InSpecta™. https://t.co/uPvM8FRota

_ @OncoSil_Medical has released the first interim findings from the OSPREY registry, reporting strong survival outcomes for patients with unresectable locally advanced pancreatic cancer treated with OncoSil™ plus gemcitabine-based chemotherapy | https://t.co/8eo8LJnXhF $OSL

_ @Optiscan_ has partnered with Australian Clinical Labs to launch the first-in-human head & neck cancer imaging study in Australia utilising the Company’s InVue® and InForm™ devices, which will be undertaken at St John of God Murdoch Hospital in Perth | https://t.co/2C0sigxHC4

Li-S Energy (ASX:LIS) has announced a collaboration with UK underwater-vehicle specialist MSubs to test its advanced lithium-sulfur batteries under deep-ocean conditions | https://t.co/PBI3sISvXr @LiS_Energy $LIS

Optiscan Imaging (ASX:OIL) is hosting an Investor Webinar, CEO Dr Camile Farah shares growth strategy, $17.75M raise, InVue®, InForm™, InSpecta™, clinical updates & partnerships. 🗓️Thu 4 December 🕐11AM AEDT 💻Zoom Register: https://t.co/HOwVUMPmeR @Optiscan_

OncoSil Medical (ASX) CEO & MD Nigel Lange presented in SYD through TCN’s investor introductions program. The company is commercialising its OncoSil™ brachytherapy device delivering targeted radiation (32P) to pancreatic tumours. https://t.co/XIsi2Hkh73

OpenLearning Limited (ASX:OLL) has signed a major three-year partnership with Field Ready in Southern Africa, combining its AI-powered LMS with a referral agreement and a global course marketplace ASX Announcement: https://t.co/XpunXlrJs6 @openlrning $OLL

OncoSil Medical (ASX:OSL) has held its FY25 Annual General Meeting, with the Chair Address and CEO Presentation at this meeting outlining the company’s many achievements over the year. Read more:  https://t.co/6QMclZ4mKj @OncoSil_Medical

The Capital Network’s latest investor briefing is now live, highlighting key market developments and a summary of the theme of the week: ✔️ @Unith_AI ✔️ @Pureprofile ✔️ @dorsavi Read the newsletter here: https://t.co/qPBTh8nF7t @TheCapNet

Zoono (ASX: ZNO) is pleased to release its 2025 Annual General Meeting presentation, outlining key agenda items for shareholders. The presentation provides an overview of the Company’s updates, business priorities, and focus areas for the year ahead | https://t.co/mFaHrEnRg9